Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REMELYN FALLE MERCADO

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology

NPI
1194302281
CMS profile
10560336
Location
LEESBURG, FL

General Payments · PY2023

$387.15

  • Reported across 18 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$387.15

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $387.15 18

By paying entity

PY2023 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $387.15 18

Payment records · PY2023 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2023
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Bayer Healthcare Pharmaceuticals Inc. $21.94 04/17/2023 Food and Beverage Undisputed 01/23/2026 1005626047 CMS
Bayer Healthcare Pharmaceuticals Inc. $25.03 07/13/2023 Food and Beverage Undisputed 01/23/2026 1005626551 CMS
Bayer Healthcare Pharmaceuticals Inc. $25.62 08/24/2023 Food and Beverage Undisputed 01/23/2026 1005626591 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.52 11/16/2023 Food and Beverage Undisputed 01/23/2026 1005624543 CMS
Calliditas Therapeutics US Inc. $29.56 06/30/2023 Food and Beverage Undisputed 01/23/2026 993486437 CMS
Exact Sciences Corporation $19.09 07/27/2023 Food and Beverage Undisputed 01/23/2026 1026877677 CMS
GlaxoSmithKline, LLC. $18.87 03/29/2023 Food and Beverage Undisputed 01/23/2026 1003949773 CMS
GlaxoSmithKline, LLC. $19.34 04/27/2023 Food and Beverage Undisputed 01/23/2026 1003948053 CMS
GlaxoSmithKline, LLC. $23.51 07/08/2023 Food and Beverage Undisputed 01/23/2026 1003948039 CMS
GlaxoSmithKline, LLC. $22.21 08/17/2023 Food and Beverage Undisputed 01/23/2026 1003948061 CMS
GlaxoSmithKline, LLC. $24.34 10/03/2023 Food and Beverage Undisputed 01/23/2026 1003949229 CMS
Lilly USA, LLC $23.64 08/04/2023 Food and Beverage Undisputed 01/23/2026 1033340259 CMS
Lilly USA, LLC $18.79 09/21/2023 Food and Beverage Undisputed 01/23/2026 1033558681 CMS
Lilly USA, LLC $19.74 11/30/2023 Food and Beverage Undisputed 01/23/2026 1033485255 CMS
Novo Nordisk Inc $19.57 01/05/2023 Food and Beverage Undisputed 01/23/2026 1002692567 CMS
Novo Nordisk Inc $23.30 09/13/2023 Food and Beverage Undisputed 01/23/2026 1002692578 CMS
Otsuka America Pharmaceutical, Inc. $18.49 06/28/2023 Food and Beverage Undisputed 01/23/2026 1015435841 CMS
Otsuka America Pharmaceutical, Inc. $17.59 08/10/2023 Food and Beverage Undisputed 01/23/2026 1015435849 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023
Source files
Dataset page · Bulk file · PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.